There are increasing challenges for manufacturers and distributors of herbal medicinal products and substance-based medical devices.
There are increasing challenges for manufacturers and distributors of herbal medicinal products and substance-based medical devices.
What needs to be considered in the new ICH Q14 Guideline "Analytical Procedure Development" and the revised Q2(R2) "Analytical Validation"?
Experience the highlights of a groundbreaking phytopharmaceutical symposium 2023! Download the exclusive conference report by Dr Markus Veit.